Controlled-release of tetracycline and lovastatin by poly(D,L-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs

• Published in: International journal of nanomedicine 2016-01, Vol.11 (Issue 1), p.285-297
• Main Authors: Lee, Bor-Shiunn, Lee, Chien-Chen, Wang, Yi-Ping, Chen, Hsiao-Jan, Lai, Chern-Hsiung, Hsieh, Wan-Ling, Chen, Yi-Wen
• Format: Article
• Language: English
• Subjects: Acids; Alcohol; Alkaline Phosphatase - metabolism; Animals; Anti-Bacterial Agents - pharmacology; Antibiotics; Antilipemic agents; Bacteria - drug effects; Biomedical materials; Bone Regeneration - drug effects; Chitosan; Chitosan - chemistry; Clinical trials; Defects; Delayed-Action Preparations - administration & dosage; Dentistry; Diabetes; Dogs; Drug Carriers - administration & dosage; Drug Carriers - chemistry; Drug delivery systems; Fourier transforms; Hydrogels; Infection control; L-lactide-co-glycolide acid; Lactic Acid - chemistry; Lovastatin; Lovastatin - administration & dosage; Lovastatin - chemistry; Lovastatin - pharmacology; Male; Microscopy, Electron, Transmission; Molecular weight; Nanoparticles; Nanoparticles - administration & dosage; Nanoparticles - chemistry; Original Research; Osteoblasts - cytology; Osteoblasts - drug effects; Particle size; Periodontal regeneration; Poly(D; Polyglycolic Acid - chemistry; Polymers; Spectrum analysis; Systematic review; Tetracycline; Tetracycline - administration & dosage; Tetracycline - chemistry; Tetracycline - pharmacology
• ISSN: 1178-2013; 1176-9114; 1178-2013
• DOI: 10.2147/IJN.S94270

Chronic periodontitis is characterized by inflammation of periodontal tissues, leading to bone resorption and tooth loss. The goal of treatment is to regenerate periodontal tissues including bone and cementum lost as a consequence of disease. The local delivery of tetracycline was proven to be effective in controlling localized periodontal infection without apparent side effects. Previous studies suggested that lovastatin has a significant role in new bone formation; however, the local delivery of lovastatin might enhance its therapeutic effects. A number of local delivery devices have been developed recently, including poly(D,L-lactide-co-glycolide acid) (PLGA) nanoparticles. The aim of this study was to develop a local delivery device, PLGA-lovastatin-chitosan-tetracycline nanoparticles, which allows the sequential release of tetracycline and lovastatin to effectively control local infection and promote bone regeneration in periodontitis. The size and microstructure of nanoparticles were examined by transmission electron microscopy, Nanoparticle Size Analyzer, and Fourier transform infrared spectroscopy. The release of tetracycline and lovastatin was quantified using a UV-Vis spectrophotometer. Furthermore, the cytotoxic effect and alkaline phosphatase activity of the nanoparticles in osteoblast cell cultures as well as antibacterial activity against periodontal pathogens were investigated. Finally, the bone regeneration potential of PLGA nanoparticles in three-walled defects in beagle dogs was investigated. The results indicated that PLGA-lovastatin-chitosan-tetracycline nanoparticles showed good biocompatibility, antibacterial activity, and increased alkaline phosphatase activity. The volumetric analysis from micro-CT revealed significantly increased new bone formation in defects filled with nanoparticles in dogs. This novel local delivery device might be useful as an adjunctive treatment in periodontal regenerative therapy.